| Hearing loss: a common disorder caused by many rare alleles D Raviv, AA Dror, KB Avraham Annals of the New York Academy of Sciences 1214 (1), 168-179, 2010 | 82 | 2010 |
| ChiTaRS-3.1—the enhanced chimeric transcripts and RNA-seq database matched with protein–protein interactions A Gorohovski, S Tagore, V Palande, A Malka, D Raviv-Shay, ... Nucleic Acids Research 45 (D1), D790-D795, 2017 | 50 | 2017 |
| A mouse model for human hearing loss DFNB30 due to loss of function of myosin IIIA VL Walsh, D Raviv, AA Dror, H Shahin, T Walsh, MN Kanaan, ... Mammalian Genome 22, 170-177, 2011 | 47 | 2011 |
| ChiTaRS 5.0: the comprehensive database of chimeric transcripts matched with druggable fusions and 3D chromatin maps D Balamurali, A Gorohovski, R Detroja, V Palande, D Raviv-Shay, ... Nucleic acids research 48 (D1), D825-D834, 2020 | 29 | 2020 |
| Sequence variation in PPP1R13L results in a novel form of cardio‐cutaneous syndrome TC Falik‐Zaccai, Y Barsheshet, H Mandel, M Segev, A Lorber, S Gelberg, ... EMBO molecular medicine 9 (3), 319-336, 2017 | 20 | 2017 |
| Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis V Palande, T Siegal, R Detroja, A Gorohovski, R Glass, C Flueh, ... Molecular Oncology 16 (10), 2098-2114, 2022 | 19 | 2022 |
| Detection of cell-free DNA in blood plasma samples of cancer patients V Palande, DR Shay, M Frenkel-Morgenstern JoVE (Journal of Visualized Experiments), e61449, 2020 | 7 | 2020 |
| Design principles of gene evolution for niche adaptation through changes in protein–protein interaction networks G Carmi, S Tagore, A Gorohovski, A Sivan, D Raviv-Shay, ... Scientific Reports 10 (1), 15628, 2020 | 1 | 2020 |
| A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targets V Palande, R Detroja, A Gorohovski, R Glass, C Flueh, M Kurtz, S Perez, ... bioRxiv, 2020.02. 25.963975, 2020 | 1 | 2020 |
| Methods and biomarkers for diagnostics, disease monitoring, personalized drug discovery and targeted therapy of autoimmune disease conditions M Frenkel-Morgenstern, R Detroja, V Palande, DR SHAY US Patent App. 17/777,497, 2023 | | 2023 |
| PATH-24. DETECTION OF POINT MUTATIONS AND GENE FUSIONS FROM CIRCULATING CELL-FREE DNA (CFDNA) OF GLIOBLASTOMA (GBM) PATIENTS M Frenkel-Morgenstern, V Palande, R Detroja, A Gorohovski, R Glass, ... Neuro-oncology 22 (Suppl 2), ii169, 2020 | | 2020 |
| PO-301 Diagnosis of glioma tumours using circulating cell-free DNA V Palande, D Raviv-Shay, M Frenkel-Morgenstern ESMO Open 3, A138-A139, 2018 | | 2018 |
